Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
—At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. —More developments arrived this week in the Sarepta Therapeutics (NASDAQ: SRPT ) saga. .
Let's personalize your content